1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Category Archives: Transplant Rejection

06Jan/12

Weekend Panorama: How Should We Judge You, Rahul? – Wall Street Journal (blog)

January 6, 2012Transplant Rejectionadmin

Weekend Panorama: How Should We Judge You, Rahul?Wall Street Journal (blog)But, if this were true, then the need for the country to understand his mettle is even more acute. Rejection of the premiership cannot, in itself, be the legitimate basis for ac…

05Jan/12

Stimulating white blood cells to fight HIV – Science Network Western Australia

January 5, 2012Transplant Rejectionadmin

Stimulating white blood cells to fight HIVScience Network Western AustraliaThe idea for this approach comes from Dr D'Orsogna's previous work in the immunology of kidney transplant rejection, where he found that T cells kill donated organ cells…

05Jan/12

CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-5 Afternoon – Beacon Equity Research

January 5, 2012Transplant Rejectionadmin

CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-5 AfternoonBeacon Equity ResearchTheir market cap is 13.45B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-thr…

05Jan/12

CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-5 Morning – Beacon Equity Research

January 5, 2012Transplant Rejectionadmin

CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-5 MorningBeacon Equity ResearchTheir market cap is 13.18B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threa…

05Jan/12

Rigel Announces Initiation of Clinical Trials in Two Immunology Programs – MarketWatch (press release)

January 5, 2012Transplant Rejectionadmin

Rigel Announces Initiation of Clinical Trials in Two Immunology ProgramsMarketWatch (press release)The company is evaluating R548, an oral JAK3 inhibitor, as a potential therapeutic for transplant rejection and other systemic immune disorders. The seco…

05Jan/12

Rigel Announces Initiation of Clinical Trials in Two Immunology Programs – PR Newswire (press release)

January 5, 2012Transplant Rejectionadmin

Rigel Announces Initiation of Clinical Trials in Two Immunology ProgramsPR Newswire (press release)The company is evaluating R548, an oral JAK3 inhibitor, as a potential therapeutic for transplant rejection and other systemic immune disorders. The seco…

05Jan/12

Alexion Continues To Please Orphan Fans – Seeking Alpha

January 5, 2012Transplant Rejectionadmin

Alexion Continues To Please Orphan FansSeeking AlphaWith trials ongoing in kidney transplant rejection, the rare blood cell disorder catastrophic anti-phospholipid syndrome and cold agglutinin disease and neurological disorders such as myasthenia gravi…

05Jan/12

Isotechnika, Vifor Pharma sign global development and commercialization … – pharmabiz.com

January 5, 2012Transplant Rejectionadmin

Isotechnika, Vifor Pharma sign global development and commercialization …pharmabiz.com“While the successful development of voclosporin for the prevention of kidney transplant rejection remains our primary focus, we believe the expansion of our plat…

04Jan/12

Goldman Sachs (GS) Analysts Reiterate a "Buy" Rating on Alexion … – LocalizedUSA

January 4, 2012Transplant Rejectionadmin

Goldman Sachs (GS) Analysts Reiterate a "Buy" Rating on Alexion …LocalizedUSA… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the th…

04Jan/12

CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-4 Morning – Beacon Equity Research

January 4, 2012Transplant Rejectionadmin

CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-4 MorningBeacon Equity ResearchTheir market cap is 13.11B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threa…

Posts navigation

  • « Previous
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 79
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos